This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations in Breast Cancer Prognosis by Matthew J Lee
Introduction
Matthew J Lee is an accomplished inventor based in Moraga, CA (US). He has made significant contributions to the field of cancer research, particularly in the area of breast cancer prognosis. His work focuses on developing innovative methods to improve patient outcomes through genetic analysis.
Latest Patents
Matthew J Lee holds a patent for a "12-gene prognostic signature for breast cancer survival." This patent involves a biomarker panel consisting of 12 genes based on their expression levels. The methods outlined in the patent include calculating prognostic scores and ranking patients based on their scores, which are divided into two equal-sized cohorts. To determine differences in survival, Kaplan-Meier analysis and a log-rank test were utilized.
Career Highlights
Matthew J Lee is affiliated with the University of California, where he continues to advance his research in cancer prognosis. His innovative approach has the potential to significantly impact the way breast cancer survival is assessed and managed.
Collaborations
He has collaborated with notable colleagues, including Antoine M Snijders and Xuan Yu Mao, to further enhance the research and development of prognostic tools in oncology.
Conclusion
Matthew J Lee's contributions to breast cancer research through his patented innovations exemplify the importance of genetic analysis in improving patient care. His work is paving the way for more effective prognostic methods in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile